Interdisciplinary Evaluation of Phytotherapy Resource Calendula Officinalis L. in Patients with Tuberculosis and Combined Pathologies

The article presents a comprehensive analysis of the pharmacotherapeutic potential and marketing aspects of the use of medicinal products based on Calendula officinalis L. in patients with tuberculosis complicated by comorbid conditions. Particular attention is paid to the clinical feasibility of using calendula herbal preparations as part of palliative and supportive therapy, taking into account frequent lesions of the gastrointestinal tract, hepatobiliary system, mucous membranes, skin, respiratory tract and genitourinary system. Based on the results of the content analysis of registration information and the assortment of the Ukrainian market, the current calendula preparations were systematized by release forms, ATC classification and manufacturers. A SWOT marketing analysis was conducted to determine the strengths and weaknesses, opportunities and threats regarding the presence of this group of herbal remedies on the domestic pharmaceutical market. Regulatory challenges were considered and proposals for their inclusion in state support programs and clinical protocols of supportive treatment were substantiated. The authors emphasize the feasibility of wider use of Calendula officinalis L. in the pharmacotherapy of tuberculosis in order to improve the quality of life of patients and increase the effectiveness of the main treatment.